Klonoff, J. Kopin, E. LaCava, S. Landgar-ten, T. Littlejohn, J. Miller, S. Miller, R.Mills, H. McIlwain, R. McInroy, A. Men-delson, T. Moretto, S. Mudaliar, L. Myers,P. Norwood, K. Osei, J. Pullman, G. Raad,A. Radparvar, R. Ratner, D. Riff, J. Robin-son, R. Rood, J. Saponaro, B. Schactman,D. Schumacher, S. Schwartz, J. Shapiro,W. Shapiro, G. Shockey, M. Strauss, J.Snyder, J. Sullivan, L. Taber, B. Troupin,W. Ward, M. Weerasinghe, R. Weinstein,D. Weiss, R. Weiss, P. Weissman, F.Whitehouse, K. Williams, M. Wofford, C.Wysham, A. Zayed, and W. Zigrang. References 1. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secre-tory dysfunction and insulin resistance inthe pathogenesis of type 2 diabetes melli-tus.J Clin Invest 104:787–794, 1999 2. UK Prospective Diabetes Study Group: UK Prospective Diabetes Study 16: Over-view of 6 years’ therapy of type II diabetes:a progressive disease. Diabetes 44:1249– 1258, 1995 3. UK Prospective Diabetes Study Group: